Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: The Italian series

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 5, 2005, Pages 2603-2609

  Ferolla, P ^a   Falchetti, A ^b   Filosso, P ^c   Tomassetti, P ^d   Tamburrano, G ^e   Avenia, N ^a   Daddi, G ^a   Puma, F ^a   Ribacchi, B R ^a   Santeusanio, F ^a   Angeletti, G ^a   Brandi, M L ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CARCINOID; CLINICAL ARTICLE; DISEASE ASSOCIATION; FAMILIAL CANCER; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERPARATHYROIDISM; ITALY; LETHALITY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SMOKING; THYMECTOMY; THYMUS CANCER;

ADULT; CARCINOID TUMOR; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; POSITRON-EMISSION TOMOGRAPHY; THYMUS NEOPLASMS;

EID: 21044455138     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1155     Document Type: Article

References (32)

1. Rosai J, Higa E 1972 Mediastinal endocrine neoplasm of probably thymic origin, related to carcinoid tumor: clinicopathologic study of 8 cases. Cancer 29:1061-1074
2. Rosai J, Higa E, Davie J 1972 Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognized association; Cancer 29:1075-1083
3. Gibril F, Chen Y, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Laurence AL, Entsuah K, Huang K, Asgharian B, Jensen RT 2003 Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88:1066-1081
4. Brandi MI, Gagel R, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells Jr SA, Marx SJ 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 12:5658-5671
5. Rosai J, Sobin LH, pathologists in eight countries 1999 WHO histological classification of tumors: histological typing of tumors of the thymus. 2nd ed. Berlin: Springer-Verlag
6. Morelli A, Falchetti A, Martineti V, Becherini L, Mark M, Friedman E, Brandi ML 2000 MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. Eur J Endocrinol 142:131-137
7. Burgess JR, Giles N, Shepherd JJ 2001 Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine enoplasia type 1. Clin Endocrinol (Oxf) 55:689-693
8. Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan P, Ho J, Khir A, Wilkinson S, Larsson C, Cameron D, Shepherd J 1997 Clinicopathologic studies of thymic carcinoid in multiple endocrine neoplasia type 1. Medicine 76:21-29
9. Teh BT, Zedenius J, Kytola S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P 1998 Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 228:99-105
10. Doherty GM, Olson J, Frisella M, Lairmore TC, Wells SA, Norton JA 1998 Lethality of multiple endocrine neoplasia type 1. World J Surg 22:581-587
11. Satta J, Ahonen A, Parkkila S, Leinonen L, Apaja-Sarkkinen M, Lepojarvi M, Juvonen T 1999 Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as new diagnostic and follow-up modality. Scand Cardiovasc J 33:49-53
12. 99mTc-M1B1 MEN type 1. J Endocrinol Invest 22:803-807
13. Groves AM, Mohan HK, Wegner EA, Hain SF, Bingham JB, Clarke SE 2004 Positron emission tomography with FDG to show thymic carcinoid. Am J Roentgenol 182:511-513
14. Nakahara T, Fujii H, Ide M, Nishiumi N, Takahashi W, Yasuda S, Shohtsu A, Kubo A 2001 FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. Br J Radiol 74:821-824
15. Wittram C, Fischman AJ, Mark E, Ko J, Shepard JA 2003 Thymic enlargement and FDG uptake in three patients: CT and FDG positron emission tomography correlated with pathology. Am J Roentgenol 180:519-522
16. Eriksson B, Bergstrom M, Sundin A, Juhlin C, Orlefors H, Oberg K, Langstrom B 2002 The role of PET in localization of neuroendocrine and adrenocortical tumors. Ann NY Acad Sci 970:159-169
17. Boix E, Pico A, Pinedo R, Aranda I, Kovacs K 2002 Ectopic growth hormone-releasing hormone secretion by thymic carcinoid rumour. Clin Endocrinol (Oxf) 57:131-134
18. Rizzoli R, Pache JC, Didierjean L, Burger A, Bonjour JP 1994 A thymoma as a cause of true ectopic hyperparathyroidism. J Clin Endocrinol Metab 79:912-915
19. Funk JL, Jones GV, Botham CA, Morgan G, Wooding P, Kendall MD 1999 Expression of parathyroid hormone-related protein and the parathyroid hormone/parathyroid hormone-related protein receptor in rat thymic epithelial cells. J Anat 194:255-264
20. Triggiani V, Lolli I, Troccoli G, Guastamacchia, Tafaro E, Ciampolillo A, Primary hyperparathyroidism associated with invasive thymoma and myastenia gravis: A case report. Proc of the 6th European Congress of Endocrinology, Lyon, France, 2003, p 216 (Abstract 0619)
21. Zeiger MA, Swartz SE, MacGillivray DC, Linnoila I, Shakir M 1992 Thymic carcinoid in association with MEN syndromes. Am Surg 58:430-434
22. Economopoulos GC, Lewis Jr JW, Lee MW, Silverman NA 1990 Carcinoid tumours of the thymus. Ann Thorac Surg 50:58-61
23. Odell WD 1990 Bronchial and thymic carcinoids and the ectopic ACTH syndrome. Ann Thorac Surg 50:5-6
24. Jansson JO, Svensson J, Bengtsson BA, Frohman LA, Ahlman H, Wangberg B, Nilsson O, Nilsson M 1998 Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6. Clin Endocrinol (Oxf) 48:243-250
25. Marchevsky AM, Dikman SH 1979 Mediastinal carcinoid with an incomplete Sipple's syndrome. Cancer 43:2497-2501
26. Seiki K, Sakabe K 1997 Sex hormones and the thymus in relation to thymocyte proliferation and maturation. Arch Histol Cytol 60:29-38
27. Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, Takizawa T, Sunamori M, Handa M, Kondo T, Sasano H 2003 Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab 88:2309-2317
28. de Montpreville VT, Macchiarini P, Dulmet E 1996 Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 111:134-141
29. Dusmet M, McKneally MF 1994 Bronchial and thymic carcinoid tumors: a review. Digestion 55:70-76
30. Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstraw P 2003 A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 124:141-146
31. Ferone, D, van Hagen PM, Kwekkeboom DJ, van Koetsveld PM, Mooy DM, Lichtenauer-Kaligis E, Schönbrunn A, Colao A, Lamberts SWJ, Hofland LJ 2000 Somatostatin receptors in human thymoma and inhibition of cell proliferation by octreotide in vitro. J Clin Endocrinol Metab 85:1719-1726
32. Palmieri G, Montella L, Martignetti A, Muto P, Di Vizio D, De Chiara A, Lastoria S 2002 Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer 94:1414-1420